Quantcast

Latest abdominal pain Stories

2014-05-15 16:27:54

NEW YORK, May, 15, 2014 /PRNewswire-USNewswire/ -- In an effort to increase their long-standing commitment of improving the lives of those with inflammatory bowel disease (IBD), the Crohn's & Colitis Foundation of America (CCFA) will host the first U.S. IBD2020 meeting from May 16(th)- May 18(th) in New Orleans, LA. http://photos.prnewswire.com/prnvar/20140515/88144 "IBD2020 USA is a critical meeting of some of the brightest minds who are thinking about both IBD and Quality of...

2014-05-13 23:10:01

New Findings for EnteraGam™ (Serum-derived bovine immunoglobulin/protein isolate, SBI) Cary, NC (PRWEB) May 13, 2014 Abigail Henderson, PhD, presented new preclinical data for the prescription medical food, EnteraGam™ (serum-derived bovine immunoglobulin/protein isolate, SBI), demonstrating that the immunoglobulin-based protein mixture in SBI binds and neutralizes two types of toxins (exotoxins A and B) from several ribotypes of C. difficile, including recently isolated strains with...

2014-05-13 00:21:38

- This Is First Study to Demonstrate Clinical Benefit of Oral alpha 4 Integrin Antagonist in Patient with Inflammatory Bowel Disease - TOKYO, May 13, 2014 /PRNewswire/ -- Ajinomoto Pharmaceuticals Co., Ltd. (President, Takashi Nagamachi; Headquarters, Tokyo, Japan) announced on May 13 that the Phase 2a results of an oral alpha 4 integrin antagonist, AJM300, in patients with ulcerative colitis were presented in the Joint Presidential Plenary Session at Digestive Disease Week (DDW)...

2014-05-05 20:24:20

LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Gastrointestinal Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expirieshttp://www.reportbuyer.com/pharma_healthcare/treatments/gastrointestinal_therapeutics_major_developed_markets_2019_new_drug_approvals_promising_pipeline_counter_declines_patent_expiries.htmlGastrointestinal Therapeutics in Major Developed Markets to...

2014-05-05 08:30:08

- The long-term safety profile was consistent with pivotal trials of Cimzia® ATLANTA, May 5, 2014 /PRNewswire/ -- UCB announced today results from the PRECiSE 3 7-year open label extension clinical trial of Cimzia(®) (certolizumab pegol), the longest continuous trial of an anti-TNF therapy evaluating long-term safety in Crohn's disease. Remission was also assessed over the trial period. Results were presented at Digestive Disease Week (DDW), taking place in Chicago from May 3-6. "The...

2014-05-05 08:29:18

ENDOCAPSULE 10 Delivers Outstanding Visualization, Improved Efficiency and Enhanced Features for Noninvasive Observation of the Small Intestine CENTER VALLEY, Pa., May 5, 2014 /PRNewswire/ -- Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today the commercial availability of its 510(k) cleared, next-generation ENDOCAPSULE 10 System for small bowel capsule endoscopy...

2014-05-05 08:28:29

Academic and Industry Teams Converge to Focus on Inflammatory Bowel Disease and Advance Innovative Interception and Prevention Strategies SPRING HOUSE, Pa., May 5, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today the establishment of a Cooperative Research and Development Agreement (CRADA) with the Naval Medical Research Center (NMRC), Prometheus Laboratories Inc. (Prometheus), Mayo Clinic, Rochester, Minnesota (Mayo Clinic), Centre Hospitalier Regional...

2014-05-03 23:02:16

The IBS Miracle is a new program developed by James Walden, who claims to teach people how to get relief from their irritable bowel syndrome quickly. An overview on the website Vinaf.com shows if the program is good for people to use. Tampa, FL (PRWEB) May 03, 2014 Irritable bowel syndrome (IBS) is a common disorder that affects people’s large intestine (colon). IBS can cause bloating gas, cramping, diarrhea, abdominal pain, and constipation. The IBS Miracle is a new program that...

2014-05-01 12:31:32

Sephure® ensures proper placement of suppositories, improves patient quality of life and compliance CONCORD, Mass., May 1, 2014 /PRNewswire/ -- Jennifer Davagian Ensign, Founder & CEO of Cristcot Inc. today announced that Sephure®, a first-of-its-kind disposable suppository applicator, is now available to the millions of people who require suppository medication therapy. Although billions of suppositories are sold around the world each year, there is no standard of care for...

2014-04-30 16:30:12

Afternoon to Honor Robbyn Sockolow, MD; Hosted by Veteran TV News Anchor Liz Cho and featuring a Fashion Presentation by Bergdorf Goodman NEW YORK, April 30, 2014 /PRNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA), Greater New York Chapter, will host their Twenty-First Annual Women of Distinction Luncheon at the Waldorf-Astoria on Thursday, May 1(st). The luncheon will be hosted by veteran WABC-TV News Anchor, Liz Cho. To purchase tickets to the 21(st) Annual...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related